HKSE:2617
TransThera Sciences (Nanjing). Inc. · HKSE · Healthcare · HKD · FY for 2025
Figures on this page computed 2026-11-08 13:27 UTC
Last close
n/aHKD
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
Price is the furthest below its sector's middle: 0.15 against 0.45 on the market's range.
- Growth-7.8%41 of 100, below its sector
- Returns on capital-71.1%13 of 100, below its sector
- Marginsn/anot placed
- Price6.4x15 of 100, below its sector
- Safety3.8776 of 100, above its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Salesn/a
Its own average over 3 years, 21.0M.
- Profit1.19x
Its own average over 5 years, -249.1M.
- Free cash flow1.08x
Its own average over 5 years, -235.5M.
- Debt0.02x
Its own average over 5 years, 100.9M.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 0.02 times.
Profit is 1.19 times its own 5-year average; Free cash flow is 1.08 times its own 5-year average; Debt is 0.02 times its own 5-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 3-year averagen/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Profit against its own 5-year average1.19
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Free cash flow against its own 5-year average1.08
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Debt against its own 5-year average0.02
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- HKD